4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-19-045763
Chief Executive Officer acquired 3,031 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GORMAN KEVIN CHARLES · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-09 | Exercise or conversion : show line 1 in the form | +3,031 | $32.99 | $99,993 | 420,628 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2019-08-09 | Exercise or conversion : show line 2 in the form Incentive Stock Option | −3,031 | $32.99 | $99,993 | $32.99 | 2025-02-03 | 3,031 | 0 | D |
Loading xslF345X03/doc4.xml…